Connect with us

Buyers Speak

New MedTech key to product acquisition by hospitals

Modern medicine has always been defined by technological innovations and advancements in science. From the moment Pierre and Marie Curie discovered the elements polonium and radium, paving the path for ground breaking X-ray technology, the roadmap was set. Since then, we have come a long way, and technologies that seemed futuristic even a few years ago, like robotics, AI, and Machine Learning, are now in the process of being used as routine to treat patients at hospitals.

These developments have been able to ensure not just precision-driven clinical outcomes but also reduced hospital stay for patients. Keeping in mind that AMRI Hospitals has always worked toward staying ahead of the curve, we have been keen on adapting and implementing latest technological systems and platforms, the benefits of which have not just helped our patients, but also our physicians, as these offer them an opportunity to keep abreast of advancements in medical science taking place around the globe.

AMRI Hospitals, serving the people of Eastern & North Eastern India, along with from across South Asia, for the last 25 years, has since its inception, set its vision on providing clinical evidence-based, value-for-money, quality health­care. The group currently runs three hospitals in the Kolkata metropolitan area, and one at Bhubaneswar, along with a number of outreach clinics. Across all its centers, AMRI has invested in a lot of advanced biomedical equipment over the years.

“We are working toward replacing our aging equipment with latest ones, since we want our hospitals to be updated with the current-generation technology.”

As part of our business plan to increase year-on-year revenue growth, we are working toward replacing our aging equipment with latest ones, since we want our hospitals to be updated with the current-generation technology. The idea is to have a faster turnaround time in our diagnostic investigations and imaging areas, as well as in surgical interventions. These investments will essentially be in areas, such as radiology, imaging, radiotherapy, surgical microscopes, nuclear medi­cine, and critical care, among others.

In the imaging area, we want to explore the possibilities of upgrading our equipment, like MRI, using AI tools, with a view to maximize utilization for more efficiency. Another area we are exploring is that of surgical robots, particularly for orthopedics and neurology.

While we are aware of current supply chain issues globally, arising from various logistic issues, shortages of microchips and critical raw material, as well as the effect of a diverse range of geo-political issues, our acquisition plan has been prepared, and will continue to be worked out, taking these factors into cognizance.

Our primary focus is on investment in acquiring systems and platforms, guided by latest technologies, in a phased manner over the next 18 months.

Our primary focus is on investment in acquiring systems and platforms, guided by latest technologies, in a phased manner over the next 18 months, with a budget outlay of around ₹100 crore. During the course of this budgetary map, the main areas where we will stress upon, with support from and in partnership with our vendor-partners, shall be on optimum energy consumption, service support, green material usage, and reduced carbon footprint.

While we already have excellent working relationship with Medtech majors like Wipro, GE Healthcare, Siemens, Philips, Elekta, Getinge India, Medtronics, and Olympus, among others, we will continue to maintain our longstanding ties with them even in the future. But we are also open to the idea of partnering with local players, since it has now become evident that India is in the midst of a Medtech Revolution, further aided by the government’s Make in India initiative.

error: Content is protected !!